Mesenchymal stromal cell infusions as rescue therapy for corticosteroid-refractory adult autoimmune enteropathy

Mayo Clinic Proceedings

Volumn 87, Issue 9, 2012, Pages 909-914

  Ciccocioppo, Rachele ^a   Russo, Maria L ^a   Bernardo, Maria E ^a   Biagi, Federico ^a   Catenacci, Laura ^a   Avanzini, Maria A ^a   Alvisi, Costanza ^a   Vanoli, Alessandro ^a   Manca, Rachele ^a   Luinetti, Ombretta ^a   Locatelli, Franco ^a   Corazza, Gino R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CORTICOSTEROID; IMMUNOGLOBULIN; METHYLPREDNISOLONE; METRONIDAZOLE; PREDNISONE;

ADULT; ADULT AUTOIMMUNE ENTEROPATHY; ANASARCA; ANTIBIOTIC THERAPY; ARTICLE; B LYMPHOCYTE; CAPSULE ENDOSCOPY; CASE REPORT; CELIAC DISEASE; CELL EXPANSION; CELL THERAPY; CORTICOSTEROID THERAPY; DISEASE COURSE; DISEASE DURATION; ENTEROPATHY; EX VIVO STUDY; FEMALE; GLUTEN FREE DIET; GOOD MANUFACTURING PRACTICE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTRAVENOUS ADMINISTRATION; LYMPHOCYTE COUNT; MALABSORPTION; MALNUTRITION; MESENCHYMAL STROMA CELL INFUSION; PARENTERAL NUTRITION; PATIENT REFERRAL; POSITRON EMISSION TOMOGRAPHY; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 84866390184     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2012.04.014     Document Type: Article

References (20)

1. Bernardo ME, Locatelli F, Fibbe WE. Mesenchymal stromal cells: a novel treatment modality for tissue repair. Ann N Y Acad Sci. 2009;1176:101-117.
2. Corazza GR, Biagi F, Volta U, Andreani ML, De Franceschi L, Gasbarrini G. Autoimmune enteropathy and villous atrophy in adults. Lancet. 1997;350(9071):106-109. (Pubitemid 27313636)
3. Kobayashi I, Imamura K, Kubota M, et al. Identification of an autoimmune enteropathy-related 75-kilodalton antigen. Gastroenterology. 1999;117(4):823-830. (Pubitemid 29468224)
4. Ciccocioppo R, D'Alò S, Di Sabatino A, et al. Mechanisms of villous atrophy in autoimmune enteropathy and celiac disease. Clin Exp Immunol. 2002;128(1):88-93. (Pubitemid 34451184)
5. Akram S, Murray JA, Pardi DS, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol. 2007;5(11):1282-1290. (Pubitemid 350019047)
6. Parekkedan B, Tilles AW, Yarmush ML. Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells. Stem Cells. 2008;26:1913-1919.
7. Verbeek WHM, Schreurs MWJ, Visser O, von Blomberg ME, Al-Toma A, Mulder CJJ. Novel approaches in the management of refractory celiac disease. Expert Rev Clin Immunol. 2008;4:205-219. (Pubitemid 351903282)
8. Le Blanc K, Frassoni F, Ball L, et al Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371(9624):1579-1586. (Pubitemid 351626841)
9. Maccario R, Podestà M, Moretta A, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigenspecific immune response favors the differentiation of CD34- T cell subsets expressing a regulatory/suppressive phenotype. Haematologica. 2005;90(4):516-525. (Pubitemid 40592895)
10. Plebani A, Mia E, Mevio E, et al. IgM and IgD concentrations in the serum and secretions of children with selective IgA defi-ciency. Clin Exp Immunol. 1983;53(3):689-696. (Pubitemid 13042358)
11. Daum S, Ipczynski R, Heine B, Schulzke JD, Aeitz M, Ullrich R. Therapy with budesonide in patients with refractory sprue. Digestion. 2006;73(1):60-68. (Pubitemid 43800663)
12. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 2005;22(3):329-341. (Pubitemid 40387475)
13. Dazzi F, Krampera M. Mesenchymal stem cells and autoimmune diseases. Best Pract Res Clin Haematol. 2011;24(1): 49-57.
14. Ciccocioppo R, Bernardo ME, Sgarella A, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut. 2011;60(6):788-798.
15. Polchert D, Sobinski J, Douglas G, et al. IFN- activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol. 2008;38(6):1745-1755.
16. Uccelli A, Prockop DJ. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr Opin Immunol. 2010; 22(6):768-774.
17. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol. 2007;37(1):129-138. (Pubitemid 46128793)
18. Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107(1): 367-372. (Pubitemid 43053565)
19. Gerdoni E, Gallo B, Casazza S, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol. 2007; 61(3):219-227. (Pubitemid 46557346)
20. Fang B, Song YP, Li N, Li J, Han Q, Zhao RC. Resolution of refractory chronic autoimmune thrombocytopenic purpura following mesenchymal stem cell transplantation: a case report. Transplant Proc. 2009;41(5):1827-1830.